Mark Christopherson
AeroLeads people directory · profile

Mark Christopherson Email & Phone Number

Chief Executive Officer at Lunair Medical
Location: Greater Minneapolis-St. Paul Area, United States, United States 12 work roles 2 schools
1 work email found @solasbio.com 3 phones found area 507 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email m****@solasbio.com
Direct phone (507) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Executive Officer
Location
Greater Minneapolis-St. Paul Area, United States, United States
Company size

Who is Mark Christopherson? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Mark Christopherson is listed as Chief Executive Officer at Lunair Medical, a company with 14 employees, based in Greater Minneapolis-St. Paul Area, United States, United States. AeroLeads shows a work email signal at solasbio.com, phone signal with area code 507, and a matched LinkedIn profile for Mark Christopherson.

Mark Christopherson previously worked as CEO, NewCo at Stealth Mode and Board Member: Bone Foam Inc at Bone Foam Inc.. Mark Christopherson holds Msee / Bsee, Integrated Circuit Design, Control Systems, Biomedical Product Development from University Of Minnesota.

Company email context

Email format at Lunair Medical

This section adds company-level context without repeating Mark Christopherson's masked contact details.

{first}@solasbio.com
86% confidence

AeroLeads found 1 current-domain work email signal for Mark Christopherson. Compare company email patterns before reaching out.

Profile bio

About Mark Christopherson

Successful Medtech executive and investor with a proven track record at Inspire Medical, NxThera, and Cryosa. Employee #1 and founding executive at both Inspire Medical and Cryosa. Expert in early therapy development through commercialization. Passionate about improving patients’ lives via innovation and execution. International development and clinical study experience. Experience in class III implantable neuro stimulation, peripheral nerve stim, cardiology, heart failure, sleep apnea, disposable catheters, RF ablation, Vapor ablation, and cryo therapies. Recognized for building high-performing cross-functional teams and strong external relationships with physicians and business partners.Therapy Development | Engineering and Operations Leadership | Clinical Studies | Regulatory | Reimbursement | Intellectual Property | Commercial Scale Up

Listed skills include Medical Devices, Cross Functional Team Leadership, Fda, R&D, and 31 others.

Current workplace

Mark Christopherson's current company

Company context helps verify the profile and gives searchers a useful next step.

Lunair Medical
Lunair Medical
Chief Executive Officer
Saint Paul, MN, US
Employees
14
AeroLeads page
12 roles

Mark Christopherson work experience

A career timeline built from the work history available for this profile.

Ceo, Newco

Current
Stealth Mode
Jun 2023 - Present

Board Member: Bone Foam Inc

Current

Corcoran, Minnesota, US

Bone Foam is an innovative orthopedic company with innovations in perioperative patient positioning and post surgical care.

Jan 2017 - Present

Entrepreneur In Residence

Chattanooga, Tennessee, US

Solas BioVentures is a Venture Capital firm that invests exclusively in the Life Science industry, focusing primarily on early and development stage Biotech, Medtech, and impactful companies. HQ is in Chattanooga, Tennessee, but our coverage is global.

Nov 2022 - Jun 2023

Senior Advisor To The Board Of Directors

Arden Hills, Minnesota, US

Nov 2022 - Jan 2023

Ceo And President Of Cryosa Inc.

Arden Hills, Minnesota, US

Cryosa is a venture backed medical device company developing treatments for obstructive sleep apnea, focusing on the root cause of the disease.

Jun 2018 - Oct 2022

Sr. Vice President Research And Development

Cardionomic Inc

Cardionomic is developing a catheter-based neuromodulation therapy for treating Acutely Decompensated Heart Failure (ADHF), a chronic condition that results in more than one million U.S. hospitalizations annually at a cost of more than $10 billion.

Sep 2015 - Feb 2018

Sr. Vice President Of Research And Development, Operations

Nxthera

NxThera developed an innovative solution for BPH (enlarged prostate). European approval of the BPH product was achieved in November 2014 and FDA clearance was received in August of 2015. NxThera was acquired by Boston Scientific in April of 2018 for $406 Million USD.

Mar 2013 - Jul 2015

Vice President, Product Development, Operations, And Quality Systems

Golden Valley, Minnesota, US

Leadership of overall system development (leads, INS, programmers), therapy development, operations, and quality systems for a class III active implantable neuro stimulator for the treatment of obstructive sleep apnea. Leadership of Operations and Quality Systems. FDA approval for the Inspire system was received in February of 2014. Inspire announced an.

Jul 2007 - Feb 2013

Core Team Leader (Therapy Leadership)

Minneapolis, MN, US

Leadership of a cross functional team of product development, marketing, clinical, and regulatory. Integration of a corporate acquisition into Medtronic and redesign and launch of a RF Ablation system for the treatment begin prostatic hyperplacia (BPH). Revenue growth of the new system exceeded 40%.

Jul 1992 - Aug 2007

Engineering Manager: Crdm Sensors And Technology

Minneapolis, MN, US

Leadership of an integrated circuit design and sensors development team. Development of implantable pressure sensors, blood oxygen sensors, and other implantable sensor research.

Nov 1998 - May 2001

Program Manager, Systems Engineering

Minneapolis, MN, US

This unique group in Medtronic applied Medtronic implantable and ablation technologies to unmet medical needs. This role included development of several neuro stimulation therapies (obstructive sleep apnea, muscle preservation, diphasia, sacral nerve stimulation) and RFablation therapies for oncology.

Jun 1993 - May 1998
2 education records

Mark Christopherson education

Msee / Bsee, Integrated Circuit Design, Control Systems, Biomedical Product Development

University Of Minnesota

Physics, Math Minor, Physics, Computer Science

Bethel University
FAQ

Frequently asked questions about Mark Christopherson

Quick answers generated from the profile data available on this page.

What company does Mark Christopherson work for?

Mark Christopherson works for Lunair Medical.

What is Mark Christopherson's role at Lunair Medical?

Mark Christopherson is listed as Chief Executive Officer at Lunair Medical.

What is Mark Christopherson's email address?

AeroLeads has found 1 work email signal at @solasbio.com for Mark Christopherson at Lunair Medical.

What is Mark Christopherson's phone number?

AeroLeads has found 3 phone signal(s) with area code 507 for Mark Christopherson at Lunair Medical.

Where is Mark Christopherson based?

Mark Christopherson is based in Greater Minneapolis-St. Paul Area, United States, United States while working with Lunair Medical.

What companies has Mark Christopherson worked for?

Mark Christopherson has worked for Lunair Medical, Stealth Mode, Bone Foam Inc., Solas Bioventures, and Cryosa Inc..

How can I contact Mark Christopherson?

You can use AeroLeads to view verified contact signals for Mark Christopherson at Lunair Medical, including work email, phone, and LinkedIn data when available.

What schools did Mark Christopherson attend?

Mark Christopherson holds Msee / Bsee, Integrated Circuit Design, Control Systems, Biomedical Product Development from University Of Minnesota.

What skills is Mark Christopherson known for?

Mark Christopherson is listed with skills including Medical Devices, Cross Functional Team Leadership, Fda, R&D, Biomedical Engineering, Commercialization, Product Development, and Iso 13485.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.